HUP0204001A2 - Helyettesített amino-metil-fenil-ciklohexán-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Helyettesített amino-metil-fenil-ciklohexán-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0204001A2 HUP0204001A2 HU0204001A HUP0204001A HUP0204001A2 HU P0204001 A2 HUP0204001 A2 HU P0204001A2 HU 0204001 A HU0204001 A HU 0204001A HU P0204001 A HUP0204001 A HU P0204001A HU P0204001 A2 HUP0204001 A2 HU P0204001A2
- Authority
- HU
- Hungary
- Prior art keywords
- optionally substituted
- group
- compounds
- alkenyl
- alkynyl
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- ULRBJKIRTCBMRW-UHFFFAOYSA-N (1-phenylcyclohexyl)methanamine Chemical class C=1C=CC=CC=1C1(CN)CCCCC1 ULRBJKIRTCBMRW-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 125000003342 alkenyl group Chemical group 0.000 abstract 4
- 125000000304 alkynyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 4
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 229910052794 bromium Inorganic materials 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 239000000460 chlorine Chemical group 0.000 abstract 2
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 239000011737 fluorine Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000005024 alkenyl aryl group Chemical group 0.000 abstract 1
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 1
- 125000005025 alkynylaryl group Chemical group 0.000 abstract 1
- -1 amino-methyl-phenyl-cyclohexane derivatives Chemical class 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány (I) illetve (Ia) általános képletű helyettesített amino-metil-fenil-ciklohexán-származékokra[mely képletben R1 és Rl'jelentése egymástól függetlenül hidrogénatom vagy adott esetbenszubsztituált alkil-, alkenil- vagy alkinilcsoport; vagy Rl és Rl'együtt -CH=CH-CH=CH- csoportot képez, mimellett az ily módonkialakított naftilrendszer helyettesítve lehet; X jelentése hidrogén-,fluor-, klór-, bróm-, jódatom, trifluor-metil-csoport, OS(O2)C6H4-pCH3, OR7 vagy OC(O)R7; ahol R7 az R4 és R5 egyedi jelentésénélfelsoroltakat jelenti; vagy ha X nincs jelen, úgy az (Ia) általánosképletű vegyületekben az A és B szénatom vagy a B és C szénatom közöttkettőskötés van jelen; R4 és R5 jelentése egymástól függetlenülhidrogénatom vagy adott esetben szubsztituált alkil-, alkenil-,alkinil-, cikloalkenil-, cikloalkil-, alkil-aril-, alkenil-aril-,alkinil-aril-, aril-, heteroaril- vagy heterociklikus-csoport; vagy R4és R5 együtt telített vagy telítetlen, adott esetben szubsztituáltcikloalkilcsoportot vagy egy megfelelő heterociklust képez; R2 és R3jelentése egymástól függetlenül R9 vagy YR9; ahol Y adott esetbenszubsztituált alkil-, alkenil- vagy alkinilcsoport; és R9 jelentésehidrogén-,fluor-, klór-, bróm-, jódatom, cianocsoport, nitrocsoport;vagy adott esetben szubsztituált alkil-, alkenil-, alkinil-,cikloalkil-, cikloalkenil- vagy heterociklikus csoport; vagy OR11,OC(O)R11, OC(O)OR11, OC(S)R11, C(O)R11, C(O)OR11, C(S)R11, C(S)OR11,SR11, S(O)R11 illetve S(O2)R11 csoport; vagy NR13R14, NR13C(O)R14,C(O)NR13R14 vagy S(O2)NR13R14 csoport; ahol R11, R13 és R14 jelentéseaz R4 és R5 egyedi jelentésénél megadott] és gyógyászatilag alkalmassavaddíciós sóikra, e vegyületek előállítására, az e vegyületekettartalmazó gyógyászati készítményekre és e vegyületeknek gyógyászatikészítmények előállítására történő felhasználására vonatkozik. Atalálmány szerinti új vegyületek fájdalomcsillapító hatássalrendelkeznek. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10000312A DE10000312A1 (de) | 2000-01-05 | 2000-01-05 | Substituierte Aminomethyl-Phenyl-Cyclohexanderivate |
| PCT/EP2000/013281 WO2001049654A2 (de) | 2000-01-05 | 2000-12-27 | Substituierte aminomethyl-phenyl-cyclohexanderivate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0204001A2 true HUP0204001A2 (hu) | 2003-11-28 |
| HUP0204001A3 HUP0204001A3 (en) | 2005-04-28 |
| HU225102B1 HU225102B1 (en) | 2006-06-28 |
Family
ID=7626853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0204001A HU225102B1 (en) | 2000-01-05 | 2000-12-27 | Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6673794B2 (hu) |
| EP (1) | EP1246793B1 (hu) |
| JP (1) | JP2003519210A (hu) |
| KR (1) | KR20020063294A (hu) |
| CN (1) | CN100379719C (hu) |
| AR (1) | AR033506A1 (hu) |
| AT (1) | ATE282021T1 (hu) |
| AU (1) | AU780547B2 (hu) |
| BR (1) | BR0016942A (hu) |
| CA (1) | CA2396304A1 (hu) |
| CO (1) | CO5251382A1 (hu) |
| CZ (1) | CZ20022337A3 (hu) |
| DE (2) | DE10000312A1 (hu) |
| ES (1) | ES2231312T3 (hu) |
| HK (1) | HK1050889A1 (hu) |
| HU (1) | HU225102B1 (hu) |
| IL (2) | IL150557A0 (hu) |
| MX (1) | MXPA02006700A (hu) |
| NO (1) | NO20022985L (hu) |
| NZ (1) | NZ520467A (hu) |
| PE (1) | PE20011044A1 (hu) |
| PL (1) | PL364873A1 (hu) |
| PT (1) | PT1246793E (hu) |
| RU (1) | RU2002120905A (hu) |
| SK (1) | SK286836B6 (hu) |
| WO (1) | WO2001049654A2 (hu) |
| ZA (1) | ZA200206151B (hu) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10049483A1 (de) * | 2000-09-29 | 2002-05-02 | Gruenenthal Gmbh | Substituierte 1-Aminobutan-3-ol-Derivate |
| DE10112198A1 (de) * | 2001-03-14 | 2002-09-19 | Gruenenthal Gmbh | Substituierte Dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amine |
| DE10224107A1 (de) * | 2002-05-29 | 2003-12-11 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit anderen Wirkstoffen zur Therapie der Harninkontinenz |
| ES2819854T3 (es) | 2002-11-22 | 2021-04-19 | Gruenenthal Gmbh | Uso de (1R,2R)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenol para tratar el dolor inflamatorio |
| US20040248979A1 (en) * | 2003-06-03 | 2004-12-09 | Dynogen Pharmaceuticals, Inc. | Method of treating lower urinary tract disorders |
| DE102005034973A1 (de) * | 2005-07-22 | 2007-02-15 | Grünenthal GmbH | Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen |
| KR100684436B1 (ko) * | 2005-09-08 | 2007-02-16 | 주식회사 다원 | 항산화, 지질과산화 억제에 따른 항노화, 항염증 및 거담 활성을 갖는 단풍마 및 가시오가피 혼합추출물을 함유하는 조성물 |
| DE102005061430A1 (de) * | 2005-12-22 | 2007-07-05 | Grünenthal GmbH | Substituierte Imidazolin-Derivate |
| DE102005061427A1 (de) * | 2005-12-22 | 2007-06-28 | Grünenthal GmbH | Substituierte Oxadiazol-Derivate |
| DE102005061428A1 (de) * | 2005-12-22 | 2007-08-16 | Grünenthal GmbH | Substituierte Cyclohexylmethyl-Derivate |
| JP5420534B2 (ja) | 2007-05-31 | 2014-02-19 | サノビオン ファーマシューティカルズ インク | モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン |
| CN113197935B (zh) * | 2021-04-13 | 2022-06-24 | 开平健之源保健食品有限公司 | 一种厚朴提取物的提取方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223541A (en) * | 1991-09-13 | 1993-06-29 | Mcneilab, Inc. | Tramadol n-oxide material, enantiomers and compositions thereof, and their use |
| IL112569A (en) * | 1994-02-10 | 1999-12-22 | Wyeth John & Brother Ltd | Pharmaceutical compositions comprising cyclohexylamine derivatives certain such novel compounds and their preparation |
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| DE19525137C2 (de) * | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
| DE19547766A1 (de) * | 1995-12-20 | 1997-06-26 | Gruenenthal Gmbh | 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe |
| DE19857475A1 (de) | 1998-12-14 | 2000-06-15 | Gruenenthal Gmbh | Substituierte Cycloheptene, deren Herstellung und Verwendung |
-
2000
- 2000-01-05 DE DE10000312A patent/DE10000312A1/de not_active Withdrawn
- 2000-12-27 HU HU0204001A patent/HU225102B1/hu not_active IP Right Cessation
- 2000-12-27 RU RU2002120905/04A patent/RU2002120905A/ru not_active Application Discontinuation
- 2000-12-27 CN CNB008192650A patent/CN100379719C/zh not_active Expired - Fee Related
- 2000-12-27 DE DE50008626T patent/DE50008626D1/de not_active Expired - Lifetime
- 2000-12-27 PL PL00364873A patent/PL364873A1/xx not_active IP Right Cessation
- 2000-12-27 IL IL15055700A patent/IL150557A0/xx active IP Right Grant
- 2000-12-27 KR KR1020027008700A patent/KR20020063294A/ko not_active Application Discontinuation
- 2000-12-27 CA CA002396304A patent/CA2396304A1/en not_active Abandoned
- 2000-12-27 JP JP2001550194A patent/JP2003519210A/ja active Pending
- 2000-12-27 BR BR0016942-0A patent/BR0016942A/pt not_active Application Discontinuation
- 2000-12-27 SK SK981-2002A patent/SK286836B6/sk not_active IP Right Cessation
- 2000-12-27 AU AU28438/01A patent/AU780547B2/en not_active Ceased
- 2000-12-27 WO PCT/EP2000/013281 patent/WO2001049654A2/de active IP Right Grant
- 2000-12-27 NZ NZ520467A patent/NZ520467A/en unknown
- 2000-12-27 CZ CZ20022337A patent/CZ20022337A3/cs unknown
- 2000-12-27 AT AT00993710T patent/ATE282021T1/de active
- 2000-12-27 EP EP00993710A patent/EP1246793B1/de not_active Expired - Lifetime
- 2000-12-27 MX MXPA02006700A patent/MXPA02006700A/es active IP Right Grant
- 2000-12-27 PT PT00993710T patent/PT1246793E/pt unknown
- 2000-12-27 ES ES00993710T patent/ES2231312T3/es not_active Expired - Lifetime
-
2001
- 2001-01-02 AR ARP010100009A patent/AR033506A1/es unknown
- 2001-01-04 CO CO01000528A patent/CO5251382A1/es not_active Application Discontinuation
- 2001-01-04 PE PE2001000010A patent/PE20011044A1/es not_active Application Discontinuation
-
2002
- 2002-06-20 NO NO20022985A patent/NO20022985L/no unknown
- 2002-07-03 IL IL150557A patent/IL150557A/en not_active IP Right Cessation
- 2002-07-05 US US10/189,190 patent/US6673794B2/en not_active Expired - Fee Related
- 2002-08-01 ZA ZA200206151A patent/ZA200206151B/xx unknown
-
2003
- 2003-04-04 HK HK03102441A patent/HK1050889A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0400710A2 (hu) | Tioéter helyettesítővel helyettesített imidazokinolinszármazékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0300148A2 (en) | Dipeptide nitrile cathepsin k inhibitors, process for their preparation and pharmaceutical compositions containing them | |
| HUP0204001A2 (hu) | Helyettesített amino-metil-fenil-ciklohexán-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0303084A2 (hu) | Gyulladásgátló hatású 17béta-karbotioát-17alfa-arilkarboniloxiloxi androsztán-származékok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0102102A2 (hu) | Pirazolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0300846A2 (hu) | Imidazopirimidin- és triazolopirimidin-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP0201646A2 (hu) | Új alfa-aminosav vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények | |
| SE0100567D0 (sv) | Compounds | |
| HUP0301195A2 (hu) | Alfa-4 integrin antagonista hatású aza-hidas biciklusos aminosav-származékok és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
| GEP20053673B (en) | Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents | |
| HUP0203316A2 (hu) | Amino-triazolopiridin-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0004024A2 (hu) | Azabenzimidazolvázas vegyületek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0103063A2 (hu) | Új 2H-piridazin-származékok, alkalmazásuk, ilyen hatóanyagot tartalmazó gyógyászati készítmények, és eljárás a hatóanyag előállítására | |
| HUP0301272A2 (hu) | 4-Fenil-piridin-származékok, mint neurokinin-1-receptor antagonisták, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására | |
| HUP0100865A2 (hu) | Meta-azaciklusos csoporttal N-szubsztituált amino-benzoesav-vegyületek és származékaik mint integrin antagonista hatóanyagok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE50304030D1 (de) | Verfahren zur Herstellung von 5-Nitrobenzofuranen | |
| HUP0002952A2 (hu) | Benzimidazolszármazékok, eljárás előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| CA2448058A1 (en) | Pyrazole derivatives as hiv reverse transcriptase inhibitors | |
| TW200616635A (en) | Novel compounds | |
| MXPA04005426A (es) | Derivados de pirazol de anillos fuisionados. | |
| JPS58172379A (ja) | 新規なキナゾリン誘導体 | |
| MXPA05014068A (es) | Dicetopiperazinas sustituidas y su uso como antagonistas de oxitocina. | |
| JP2005506970A5 (hu) | ||
| NO920432L (no) | Cykloalkylenazoler, fremgangsmaate for fremstilling av disse, farmasoeytiske preparater som inneholder disse, saavel som deres anvendelse for fremstilling av legemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |